PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.89%
Negative revenue growth while AVGO stands at 8.54%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-8.13%
Negative gross profit growth while AVGO is at 10.89%. Joel Greenblatt would examine cost competitiveness or demand decline.
-13.11%
Negative EBIT growth while AVGO is at 33.49%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-12.58%
Negative operating income growth while AVGO is at 33.49%. Joel Greenblatt would press for urgent turnaround measures.
-73.23%
Negative net income growth while AVGO stands at 32.22%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-72.87%
Negative EPS growth while AVGO is at 33.33%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-73.02%
Negative diluted EPS growth while AVGO is at 36.36%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.30%
Share reduction while AVGO is at 0.25%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.10%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
23.81%
Dividend growth above 1.5x AVGO's 12.46%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
12.02%
OCF growth at 50-75% of AVGO's 18.30%. Martin Whitman would question if the firm lags in monetizing sales effectively.
10.55%
FCF growth under 50% of AVGO's 23.20%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
46.89%
10Y revenue/share CAGR under 50% of AVGO's 468.39%. Michael Burry would suspect a lasting competitive disadvantage.
42.24%
5Y revenue/share CAGR under 50% of AVGO's 372.60%. Michael Burry would suspect a significant competitive gap or product weakness.
21.89%
3Y revenue/share CAGR under 50% of AVGO's 89.66%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
88.82%
10Y OCF/share CAGR under 50% of AVGO's 801.33%. Michael Burry would worry about a persistent underperformance in cash creation.
100.89%
Below 50% of AVGO's 449.38%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
61.14%
3Y OCF/share CAGR under 50% of AVGO's 220.10%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-36.54%
Negative 10Y net income/share CAGR while AVGO is at 1753.27%. Joel Greenblatt sees a major red flag in long-term profit erosion.
47.24%
Below 50% of AVGO's 141.18%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-55.69%
Negative 3Y CAGR while AVGO is 193.29%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
44.34%
Below 50% of AVGO's 1271.06%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
6.56%
Below 50% of AVGO's 408.20%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
5.71%
Below 50% of AVGO's 291.40%. Michael Burry suspects a serious short-term disadvantage in building book value.
516.71%
Dividend/share CAGR of 516.71% while AVGO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
193.79%
Below 50% of AVGO's 543.14%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
82.37%
Below 50% of AVGO's 219.73%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-18.91%
Firm’s AR is declining while AVGO shows 1.28%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.57%
Inventory growth well above AVGO's 1.12%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.21%
Asset growth well under 50% of AVGO's 8.96%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-5.64%
We have a declining book value while AVGO shows 2.36%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
13.79%
Debt shrinking faster vs. AVGO's 29.30%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
2.93%
R&D growth drastically higher vs. AVGO's 0.12%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-0.73%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.